Clinical trial
Hydrochlorothiazide (+) Losartan Potassium vs. Amlodipine Comparative Study…
NCT00157963 · Organon and Co, Industry · Completed
Key facts
| NCT number | NCT00157963 |
|---|---|
| Title | Hydrochlorothiazide (+) Losartan Potassium vs. Amlodipine Comparative Study (0954A-314) |
| Official title | A 12 Week, Open, Randomized, Parallel, Multicenter Study of Efficacy, Tolerability & Safety of Hydrochlorothiazide (+) Losartan Potassium Versus Amlodipine in Essential Hypertensive Patients. |
| Lead sponsor | Organon and Co, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Essential Hypertension |
| Intervention type | Drug |
| Interventions | MK0954A, hydrochlorothiazide (+) losartan potassium / Duration of Treatment: 12 weeks |
| Enrollment | 174 |
| Start date | Feb 5, 2005 |
| Primary completion | Feb 8, 2006 |
| Completion | Feb 8, 2006 |
| First posted | Sep 12, 2005 |
| Last update posted | Aug 15, 2024 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: